ASTRAZENECA PLC
Business
AstraZeneca is a global innovation-driven biopharmaceutical company that discovers, develops, and commercializes prescription medicines across oncology, cardiovascular-renal-metabolic disease, respiratory & immunology, vaccines & immune therapies, and rare disease. The company markets branded pharmaceutical products directly to customers worldwide and maintains an extensive pipeline of clinical-stage candidates. AstraZeneca operates through five reportable segments corresponding to its primary therapeutic areas, with significant geographic presence in the United States, Europe, China, and other emerging and established markets.
Summary from 20-F filed 2026-02-24
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $10.23B |
| Total assets | $114.07B |
| Total liabilities | $65.36B |
| Stockholders' equity | — |
| Operating cash flow | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is ASTRAZENECA PLC's CIK number?
ASTRAZENECA PLC's SEC CIK number is 0000901832 (901832). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find ASTRAZENECA PLC's SEC filings?
All of ASTRAZENECA PLC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.